Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
MYD:FRA
Myriad Genetics Inc
3,95 €
-3,16%
(-0,13) 1D
30 apr, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MYD...
Açın
3,95 €
High
3,95 €
Low
3,95 €
Mkt. cap
453,33 mln
Avg. vol.
359,00
Volume
0,00
52-wk high
7,10 €
52-wk low
3,30 €
No. of employees
3K
News stories
From sources across the web
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2,7K
Founded1991
HeadquartersSolt Leyk Siti, Yuta, Amerika Birləşmiş Ştatları
Sector-
Websitemyriad.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
195,90 mln
213,10 mln
205,70 mln
209,80 mln
Cost of goods sold
61,70 mln
61,30 mln
61,90 mln
63,00 mln
Cost of revenue
61,70 mln
61,30 mln
61,90 mln
63,00 mln
Research and development expenses
27,50 mln
25,60 mln
28,20 mln
25,50 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
135,70 mln
138,70 mln
138,90 mln
124,30 mln
Operating expense
163,20 mln
164,30 mln
167,10 mln
149,80 mln
Total operating expenses
224,90 mln
225,60 mln
229,00 mln
212,80 mln
Operating income
-29,00 mln
-12,50 mln
-23,30 mln
-3,00 mln
Other non operating income
100,00K
-100,00K
400,00K
400,00K
EBT including unusual items
-29,40 mln
-330,60 mln
-26,20 mln
-8,90 mln
EBT excluding unusual items
-29,40 mln
-13,90 mln
-26,20 mln
-6,20 mln
Income tax expense
-29,30 mln
-100,00K
1,20 mln
-1,00 mln
Effective tax rate
99,66%
0,03%
-4,58%
11,24%
Other operating expenses
-
-
-
-
Net income
-100,00K
-330,50 mln
-27,40 mln
-7,90 mln
Net profit margin
-0,05%
-155,09%
-13,32%
-3,77%
Earnings per share
-0,03
0,05
-
0,04
Interest and investment income
300,00K
200,00K
500,00K
800,00K
Interest expense
-800,00K
-1,50 mln
-3,80 mln
-4,40 mln
Net interest expenses
-500,00K
-1,30 mln
-3,30 mln
-3,60 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,60 mln
1,60 mln
-10,70 mln
9,60 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer